Pharmacist-led intervention to improve treatment outcomes in type 2 diabetes: a randomized controlled trial

IF 0.5 Q4 HEALTH CARE SCIENCES & SERVICES
M. Ihekoronye, K. Osemene, T. Oamen
{"title":"Pharmacist-led intervention to improve treatment outcomes in type 2 diabetes: a randomized controlled trial","authors":"M. Ihekoronye, K. Osemene, T. Oamen","doi":"10.1093/jphsr/rmae005","DOIUrl":null,"url":null,"abstract":"\n \n \n Pharmacists’ contribution to medication therapy management in type 2 diabetes (T2D) is under-reported in Nigeria. This study evaluated the effectiveness of a pharmacy-based intervention on knowledge, pharmacy refills, medication adherence, and glycemic control among patients with T2D.\n \n \n \n A two-arm prospective, randomized, controlled trial among 309 T2D patients over 25 weeks duration was conducted in a tertiary hospital. The intervention group (n = 155) received weekly health education and follow-up sent as phone-based short message service (SMS), alongside standard care. Control group (n = 154) received only standard care. Primary (HbA1c reduction) and secondary (refill adherence, knowledge, and medication adherence) outcomes were assessed and compared in both groups at baseline and endline.\n \n \n \n Intervention improved glycemic control (HbA1c reduction) directly (t = 8.253, P < .001) and indirectly through improved pharmacy refill adherence as 115 (76%) of the intervention group were refill adherent (Proportion of Days Covered [PDC] > 80%). For controls, mean baseline and endline knowledge scores were 2.798 and 2.816, respectively (t = 1.19092, P > .005), while the intervention group had 2.732 and 4.462, respectively (t = 9.76157, P < .005) on a 5-point Likert scale. Baseline and endline adherence scores for control group were 3.41 and 3.50, respectively (t = 0.92477, P > .05), while the intervention group had 3.35 and 6.72, respectively (t = 17.87981, P < .05) on the 8-point Morisky Medication Adherence Scale (MMAS-8).\n \n \n \n Pharmacist-led intervention significantly improved medication refills, glycemic control, knowledge, and medication adherence. Pharmacists should exploit mobile telephony for health education and follow-up services to improve treatment outcomes in medication therapy management of T2D.\n","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Health Services Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jphsr/rmae005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Pharmacists’ contribution to medication therapy management in type 2 diabetes (T2D) is under-reported in Nigeria. This study evaluated the effectiveness of a pharmacy-based intervention on knowledge, pharmacy refills, medication adherence, and glycemic control among patients with T2D. A two-arm prospective, randomized, controlled trial among 309 T2D patients over 25 weeks duration was conducted in a tertiary hospital. The intervention group (n = 155) received weekly health education and follow-up sent as phone-based short message service (SMS), alongside standard care. Control group (n = 154) received only standard care. Primary (HbA1c reduction) and secondary (refill adherence, knowledge, and medication adherence) outcomes were assessed and compared in both groups at baseline and endline. Intervention improved glycemic control (HbA1c reduction) directly (t = 8.253, P < .001) and indirectly through improved pharmacy refill adherence as 115 (76%) of the intervention group were refill adherent (Proportion of Days Covered [PDC] > 80%). For controls, mean baseline and endline knowledge scores were 2.798 and 2.816, respectively (t = 1.19092, P > .005), while the intervention group had 2.732 and 4.462, respectively (t = 9.76157, P < .005) on a 5-point Likert scale. Baseline and endline adherence scores for control group were 3.41 and 3.50, respectively (t = 0.92477, P > .05), while the intervention group had 3.35 and 6.72, respectively (t = 17.87981, P < .05) on the 8-point Morisky Medication Adherence Scale (MMAS-8). Pharmacist-led intervention significantly improved medication refills, glycemic control, knowledge, and medication adherence. Pharmacists should exploit mobile telephony for health education and follow-up services to improve treatment outcomes in medication therapy management of T2D.
以药剂师为主导的干预措施改善 2 型糖尿病的治疗效果:随机对照试验
在尼日利亚,药剂师对 2 型糖尿病(T2D)药物治疗管理的贡献还未得到充分报道。本研究评估了以药房为基础的干预措施对 2 型糖尿病患者的知识、药房补药、服药依从性和血糖控制的效果。 在一家三级医院对 309 名 T2D 患者进行了为期 25 周的双臂前瞻性随机对照试验。干预组(155 人)在接受标准护理的同时,每周还接受以电话短信服务(SMS)形式发送的健康教育和随访。对照组(n = 154)只接受标准护理。在基线和终点对两组的主要结果(HbA1c 降低)和次要结果(续药依从性、知识和用药依从性)进行评估和比较。 干预直接改善了血糖控制(HbA1c 降低)(t = 8.253,P < .001),并通过改善药房续药依从性间接改善了血糖控制,因为干预组中有 115 人(76%)坚持续药(覆盖天数比例 [PDC] > 80%)。对照组的基线和终点知识平均分分别为 2.798 分和 2.816 分(t = 1.19092,P > .005),而干预组的基线和终点知识平均分分别为 2.732 分和 4.462 分(t = 9.76157,P < .005)。在莫里斯基用药依从性 8 分量表(MMAS-8)上,对照组的基线和终点依从性得分分别为 3.41 分和 3.50 分(t = 0.92477,P > .05),而干预组的基线和终点依从性得分分别为 3.35 分和 6.72 分(t = 17.87981,P < .05)。 药剂师主导的干预大大改善了药物补充、血糖控制、知识和用药依从性。药剂师应利用移动电话开展健康教育和随访服务,以改善 T2D 药物治疗管理的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Health Services Research
Journal of Pharmaceutical Health Services Research HEALTH CARE SCIENCES & SERVICES-
CiteScore
1.50
自引率
0.00%
发文量
45
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信